EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The role of CD74 in cardiovascular disease

Qiu-Lin Li, Jing Tang, Ling Zhao, Amanguli Ruze, Xue-Feng Shan, Xiao-Ming Gao

Frontiers in Cardiovascular Medicine · 12.01.2023 · 9

DOI: 10.3389/fcvm.2022.1049143 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 12.01.2023. Verfasst von Qiu-Lin Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asian, Department of Cardiology, The First Affil…. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Xinjiang Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leukocyte differentiation antigen 74 (CD74), also known as invariant chain, is a molecular chaperone of major histocompatibility complex class II (MHC II) molecules involved in antigen presentation. CD74 has recently been shown to be a receptor for the macrophage migration inhibitory factor family proteins (MIF/MIF2). Many studies have revealed that CD74 plays an important role in cardiovascular disease. In this review, we summarize the structure and main functions of CD74 and then focus on the recent research progress on the role of CD74 in cardiovascular diseases. In addition, we also discuss potential treatment strategies that target CD74. Our systematic review of the role of CD74 in cardiovascular disease will fill some knowledge gaps in the field.

Schlagwörter

Stichwörter der Autor:innen

CD74D-DT/MIF2MIFcardiovascular diseasesinvariant chain

Autor:innen und Institutionen

  • State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asian, Department of Cardiology, The First Affiliated Hospital of Xinjiang Medical University, Ürümqi, China.
  • Xinjiang Key Laboratory of Medical Animal Model Research, Ürümqi, China.
  • Department of Clinical Laboratory, The First Affiliated Hospital of Xinjiang Medical University, Ürümqi, China.
  • Clinical Medical Research Institute of Xinjiang Medical University, Ürümqi, China.

Förderung

  • National Natural Science Foundation of China
  • Xinjiang Medical University

Zitieren

APA

Li, Q. L., Tang, J., Zhao, L., Ruze, A., Shan, X. F., & Gao, X. M. (2023). The role of CD74 in cardiovascular disease. Frontiers in Cardiovascular Medicine, 9. https://doi.org/10.3389/fcvm.2022.1049143

Vancouver

Li QL, Tang J, Zhao L, Ruze A, Shan XF, Gao XM. The role of CD74 in cardiovascular disease. Frontiers in Cardiovascular Medicine. 2023;9. doi:10.3389/fcvm.2022.1049143

BibTeX
@article{Li2023,
  author = {Li, Qiu-Lin and Tang, Jing and Zhao, Ling and Ruze, Amanguli and Shan, Xue-Feng and Gao, Xiao-Ming},
  title = {The role of CD74 in cardiovascular disease},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2023},
  volume = {9},
  doi = {10.3389/fcvm.2022.1049143}
}
Kostenlos starten →